Quality-of-life analysis with intermittent vismodegib regimens in patients with multiple basal cell carcinomas: patient-reported outcomes from the MIKIE study.
Dirk SchadendorfA HauschildS FoskoD ZlotyB LabeilleJ-J GrobS PuigM MakrutzkiF GilbergA HongBrigitte DrenoG RogersR KunstfeldPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)